Genetics of sickle cell-associated cardiovascular disease: An expert review with lessons learned in Africa

OMICS A Journal of Integrative Biology

Volumn 20, Issue 10, 2016, Pages 581-592

  Geard, Amy ^a   Pule, Gift D ^a   Chelo, David ^b   Bitoungui, Valentina Josiane Ngo ^b   Wonkam, Ambroise ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Africa; global precision medicine; kidney disease; pulmonary hypertension; sickle cell disease; stroke

Indexed keywords

AFRICA; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; GENETIC RISK; GENETICS; HUMAN; KIDNEY DISEASE; META ANALYSIS (TOPIC); PERSONALIZED MEDICINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SICKLE CELL ANEMIA; SYSTEMATIC REVIEW; CARDIOVASCULAR DISEASES; COMPLICATION; GENOME-WIDE ASSOCIATION STUDY;

AFRICA; ANEMIA, SICKLE CELL; CARDIOVASCULAR DISEASES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KIDNEY DISEASES; PRECISION MEDICINE;

EID: 84991467117     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2016.0125     Document Type: Review

References (111)

1. Adams GT, Snieder H, McKie VC, et al. (2003). Genetic risk factors for cerebrovascular disease in children with sickle cell disease: Design of a case-control association study and genomewide screen. BMC Med Genet 4, 6.
2. Adams RJ. (2005). TCD in sickle cell disease: An important and useful test. Pediatr Radiol 35, 229-234.
3. Adams RJ, Kutlar A, McKie V, et al (1994). Alpha thalassemia and stroke risk in sickle cell anemia.AmJHematol 45, 279-282
4. Adams RJ, McKie VC, Hsu L, et al. (1998). Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 339, 5-11.
5. Adams RJ, McKie VC, Nichols F, et al. (1992). The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 326, 605-610.
6. Adams RJ, Ohene-Frempong K, and Wang W. (2001). Sickle cell and the brain. Hematology Am Soc Hematol Educ Program 2001, 31-46.
7. Adedoyin OT, Adesiyun OO, Adegboye OA, Bello OA, and Fatoye OP. (2012). Sickle cell nephropathy in children seen in an African Hospital-Case Report. Niger Postgrad Med J 19, 119-122.
8. Akingbola TS, Tayo BO, Salako B, et al. (2014). Comparison of patients from Nigeria and the USA highlights modifiable risk factors for sickle cell anemia complications. Hemoglobin 38, 236-243.
9. Aliyu ZY, Gordeuk V, SachdevV, et al. (2008). Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. Am J Hematol 83, 485-490.
10. Aliyu ZY, Suleiman A, Attah E, et al. (2010). NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in Africa. Br J Haematol 150, 102-107.
11. Ashley-Koch AE, Okocha EC, Garrett ME, et al. (2011). MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol 155, 386-394.
12. Athale UH, and Chintu C. (1994). Clinical analysis of mortality in hospitalized Zambian children with sickle cell anaemia. East Afr Med J 71, 388-391.
13. Barisoni L, and Nelson PJ. (2007). Collapsing glomerulopathy: An inflammatory podocytopathy? Curr Opin Nephrol Hypertens 16, 192-195.
14. Bean CJ, Boulet SL, Ellingsen D, et al. (2012). Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood 120, 3822-3828.
15. Becton LJ, Kalpatthi RV, Rackoff E, et al. (2010). Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr Nephrol 25, 1505-1511.
16. Behar DM, Rosset S, Tzur S, et al. (2010). African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans. Hum Mol Genet 19, 1816-1827.
17. Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, and Vercellotti GM. (2006). Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J Clin Invest 116, 808-816.
18. Bhatnagar P, Barron-Casella E, Bean CJ, et al. (2013). Genomewide meta-Analysis of systolic blood pressure in children with sickle cell disease. PLoS One 8, e74193.
19. Black M, Wang W, and Wang W. (2015). Ischemic stroke: From next generation sequencing and GWAS to community genomics? OMICS 19, 451-460.
20. Charache S, Terrin ML, Moore RD, et al. (1995). Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 332, 1317-1322.
21. Chobanian AV, Bakris GL, Black HR, et al. (2003). Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206-1252.
22. Cox SE, Makani J, Soka D, et al. (2014). Haptoglobin, alphathalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania. Br J Haematol 165, 699-706.
23. Cox SE, Soka D, Kirkham FJ, et al. (2014). Tricuspid regurgitant jet velocity and hospitalization in Tanzanian children with sickle cell anemia. Haematologica 99, e1-e4.
24. Cressman MD, and Gifford RW. (1983). Hypertension and stroke. Am J Cardiol 1, 521-527.
25. DeBaun MR, Glauser TA, Siegel M, Borders J, and Lee B. (1995). Noninvasive central nervous system imaging in sickle cell anemia. A preliminary study comparing transcranial Doppler with magnetic resonance angiography. J Pediatr Hematol Oncol 17, 29-33.
26. Desai AA, Zhou T, Ahmad H, et al. (2012). A novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease. Am J Respir Crit Care Med 186, 359-368.
27. Diagne I, Ndiaye O, Moreira C, et al. (2000). Les syndromes drépanocytaires majeurs en pédiatrie a' Dakar (Sénégal). Arch Pédiatr 7, 16-24.
28. Diallo D and Tchernia G. (2002). Sickle cell disease in Africa. Curr Opin Hematol 9, 111-116.
29. Diop S, Thiam D, Cisse M, Toure-Fall AO, Fall K, and Diakhate L. (1999). New results in clinical severity of homozygous sickle cell anemia, in Dakar, Senegal. Hematol Cell Ther 41, 217-221.
30. Driscoll MC, Hurlet A, Berman B, Files B, and Byrne J. (1997). Stroke in SIB-pairs with sickle cell disease. Blood 90, 1160.
31. Driscoll MC, Hurlet A, Styles L, et al. (2003). Stroke risk in siblings with sickle cell anemia. Blood 101, 2401-2404.
32. Dubow J, and Fink ME. (2011). Impact of hypertension on stroke. Curr Atheroscler Rep 13, 298-305.
33. Earley CJ, Kittner SJ, Feeser BR, et al. (1998). Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology 51, 169-176.
34. Enakpene EO, Adebiyi AA, Ogah OS, et al. (2014). Noninvasive estimation of pulmonary artery pressures in patients with sickle cell anaemia in Ibadan, Nigeria: An echocardiographic study. Acta Cardiol 69, 505-511.
35. Enosolease ME, Ejele OA, and Awodu OA. (2005). The influence of foetal haemoglobin on the frequency of vaso-occlusive crisis in sickle cell anaemia patients. Niger Postgrad Med J 12, 102-105.
36. Fatunde OJ, and Scott-Emuakpor AB. (1992). Foetal haemoglobin in Nigerian children with sickle cell anaemia. Effect on haematological parameters and clinical severity. Trop Geogr Med 44, 264-266.
37. Flanagan JM, Frohlich DM, Howard TA, et al. (2011). Genetic predictors for sroke in children with sickle cell anemia. Blood J Am Soc Hematol 117, 6681-6684.
38. Flanagan JM, Sheehan V, Linder H, et al. (2013). Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood 121, 3237-3245.
39. Fonseca GH, Souza R, Salemi VM, Jardim C V, and Gualandro SF. (2012). Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease. Eur Respir J 39, 112-118.
40. Forero DA, Wonkam A, Wang W, et al. (2016). Current needs for human and medical genomics research infrastructure in low and middle income countries. J Med Genet 53, 438-40.
41. Genovese G, Friedman DJ, Ross MD, et al. (2010). Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329, 841-845.
42. Gladwin MT, Sachdev V, Jison ML, et al. (2004). Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 350, 886-895.
43. Gordeuk VR, Sachdev V, Taylor JG, Gladwin MT, Kato G, and Castro OL. (2008). Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Am J Hematol 83, 15-18.
44. Guasch A, Cua M, and Mitch WE. (1996). Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney Int 49, 786-791.
45. Guasch A, Navarrete J, Nass K, and Zayas CF. (2006). Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol 17, 2228-2235.
46. Guasch A, Zayas CF, Eckman JR, Muralidharan K, Zhang W, and Elsas LJ. (1999). Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol 10, 1014-1019.
47. Hirai H, Kubo H, Yamaya M, et al. (2003). Brief report Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Apoptosis 102, 2002-2004.
48. Hoppe C, Cheng S, Grow M, et al. (2001). A novel multilocus genotyping assay to identify genetic predictors of stroke in sickle cell anaemia. Br J Haematol 114, 718-720.
49. Hoppe C, Klitz W, Cheng S, et al. (2004). Gene interactions and stroke risk in children with sickle cell anemia. Blood 103, 2391-2397.
50. Hoppe C, Klitz W, Noble J, Vigil L, Vichinsky E, and Styles L. (2003). Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood 101, 2865-2869.
51. Hsu LL, Miller ST, Wright E, et al. (2003). Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J Pediatr Hematol Oncol 25, 622-628.
52. Iwalokun BA, Iwalokun SO, Hodonu SO, Aina OA, and Agomo PU. (2012). Evaluation of microalbuminuria in relation to asymptomatic bacteruria in Nigerian patients with sickle cell anemia. Saudi J Kidney Dis Transpl 23, 1320-1330.
53. Kanakiriya S, Croatt AJ, Haggard JJ, et al. (2003). Heme: A novel inducer of MCP-1 through HO-dependent and HOindependent mechanisms. Am J Physiol-Ren Physiol 284, F546-F554.
54. Kannel WB, Dawber TR, Sorlie P and Wolf PA. (1976). Components of blood pressure and risk of atherothrombotic brain infarction: The Framingham study. Stroke 7, 327-331.
55. Kannel WB, Wolf PA, Verter J, and McNamara PM. (1970). Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA 214, 301-310.
56. Kao WH, Klag MJ, Meoni LA, et al. (2008). MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 40, 1185-1192.
57. Kasembeli AN, Duarte R, Ramsay M, et al. (2015). APOL1 risk variants are strongly associated with HIV-Associated nephropathy in Black South Africans. J Am Soc Nephrol 26, 2882-90.
58. Kasembeli AN, Duarte R, Ramsay M, and Naicker S. (2015). African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era. World J Nephrol 4, 295-306.
59. Kernan WN, Ovbiagele B, Black HR, et al. (2014). Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45, 2160-2236.
60. Kinney TR, Sleeper LA, Wang WC, et al. (1999). Silent cerebral infarcts in sickle cell anemia: A risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics 103, 640-645.
61. Koko J, Dufillot D, M'Ba-Meyo J, Gahouma D, amd Kani F. (1998). Mortality of children with sickle cell disease in a pediatric department in Central Africa. Arch Pediatr 5, 965-969.
62. Kopp JB, Smith MW, Nelson GW, et al. (2008). MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40, 1175-1184.
63. Kwiatkowski JL, Hunter JV, Smith-Whitley K, Katz ML, Shults J, and Ohene-Frempong K. (2003). Transcranial Doppler Ultrasonography in siblings with sickle cell disease. Br J Haematol 121, 932-937.
64. Lagunju I, Sodeinde O, and Telfer P. (2012). Prevalence of transcranial Doppler abnormalities in Nigerian children with sickle cell disease. Am J Hematol 87, 544-547.
65. Lettre G, Sankaran VG, Bezerra MA, et al. (2008). DNA polymorphisms at the BCL11A, HBS1L-MYB, and betaglobin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA 105, 11869-11874.
66. Makani J, Kirkham FJ, Komba A, et al. (2009). Risk factors for high cerebral blood flow velocity and death in Kenyan children with Sickle Cell Anaemia: Role of haemoglobin oxygen saturation and febrile illness. Br J Haematol 145, 529-532.
67. Makani J, Williams TN, and Marsh K. (2007). Sickle cell disease in Africa: Burden and research priorities. Ann Trop Med Parasitol 101, 3-14.
68. Mehari A, Gladwin MT, Tian X, Machado RF, and Kato GJ. (2012). Mortality in adults with sickle cell disease and pulmonary hypertension. JAMA 307, 1254-1256.
69. Meissner I, Whisnant JP, and Garraway WM. (1988). Hypertension Management and Stroke Recurrence in a Community (Rochester, Minnesota, 1950-1979). Stroke 19, 459-463.
70. Moher D, Liberati A, Tetzlaff J, Altman DG; The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement. PLoS Med 6, e1000097.
71. Moser FG, Miller ST, Bello JA, et al. (1996). The spectrum of brain MR abnormalities in sickle-cell disease: A report from the Cooperative Study of Sickle Cell Disease. Am J Neuroradiol 17, 965-972.
72. Nath KA, Grande JP, Haggard JJ, et al. (2001). Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol 158, 893-903.
73. Nath KA, and Katusic ZS. (2012). Vasculature and kidney complications in sickle cell disease. J Am Soc Nephrol 23, 781-784.
74. Nelson GW, Freedman BI, Bowden DW, et al. (2010). Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum Mol Genet 19, 1805-1815.
75. Njamnshi AK, Mbong EN, Wonkam A, et al. (2006). The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon. J Neurol Sci 250, 79-84.
76. Nowak-Göttl U, Sträter R, Heinecke A, et al. (1999). Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 94, 3678-3682.
77. Oguanobi NI, Onwubere BJC, Ibegbulam OG, et al. (2010). Arterial blood pressure in adult Nigerians with sickle cell anemia. J Cardiol 56, 326-331.
78. Ohene-Frempong K. (1991). Stroke in sickle cell disease: Demographic, clinical, and therapeutic considerations. Semin Hematol 28, 213-219.
79. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. (1998). Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 91, 288-294.
80. Osei-Yeboah CT, and Rodrigues O. (2011). Renal status of children with sickle cell disease in Accra, Ghana. Ghana Med J 45, 155-160.
81. Pakasa NM, and Sumaili EK. (2012). Pathological peculiarities of chronic kidney disease in patient from sub-Saharan Africa. Review of data from the Democratic Republic of the Congo. Ann Pathol 32, 40-52.
82. Parent F, Bachir D, Inamo J, et al. (2011). A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med 365, 44-53.
83. Pegelow CH, Colangelo L, Steinberg M, et al. (1997). Natural history of blood pressure in sickle cell disease: Risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med 102, 171-177.
84. Pham PT, Pham PT, Wilkinson AH, and Lew SQ. (2000). Renal abnormalities in sickle cell disease. Kidney Int 57, 1-8.
85. Piel FB, Patil AP, Howes RE, et al. (2013). Global epidemiology of sickle haemoglobin in neonates: A contemporary geostatistical model-based map and population estimates. Lancet 381, 142-151.
86. Platt OS, Brambilla DJ, Rosse WF, et al. (1994). Mortality in sickle cell disease. N Engl J Med 330, 1639-16344.
87. Platt OS, Thorington BD, Brambilla DJ, et al. (1991). Pain in sickle cell disease rates and risk factors. N Engl J Med 325, 11-16.
88. Powars D, Wilson B, Imbus C, Pegelow C, and Allen J. (1978). The natural history of stroke in sickle cell disease. Am J Med 65, 461-471.
89. Powars DR, Chan L, and Schroeder WA. (1990). Beta S-genecluster haplotypes in sickle cell anemia: Clinical implications. Am J Pediatr Hematol Oncol 12, 367-374.
90. Powars DR, Elliott-Mills DD, Chan L, et al. (1991). Chronic renal failure in sickle cell disease: Risk factors, clinical course, and mortality. Ann Intern Med 115, 614-620.
91. Ruffieux N, Njamnshi AK, Wonkam A, et al. (2013). Association between biological markers of sickle cell disease and cognitive functioning amongst Cameroonian children. Child Neuropsychol 19, 143-160.
92. Rumaney MB, Ngo Bitoungui VJ, Vorster AA, et al. (2014). The co-inheritance of alpha-Thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival. PLoS One 9, 1-10.
93. Saraf SL, Zhang X, Shah B, et al. (2015). Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy. Haematologica 100, 1275-1284.
94. Schrader J, Röthemeyer M, Lüders S, and Kollmann K. (1998). Hypertension and stroke-Rationale behind the ACCESS trial. Basic Res Cardiol 93 Suppl 2, 69-78.
95. Sebastiani P, Ramoni MF, Nolan V, Baldwin CT, and Steinberg MH. (2005). Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet 37, 435-440.
96. Serjeant GR. (2005). Mortality from sickle cell disease in Africa. BMJ 330, 432-433.
97. Steinberg MH. (2005). Predicting clinical severity in sickle cell anaemia. Br J Haematol 129, 465-481.
98. Steinberg MH, Barton F, Castro O, et al. (2003). Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment. JAMA 289, 1645-1651.
99. Stockman JA, Nigro MA, Mishkin MM, and Oski FA. (1972). Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med 287, 846-849.
100. Stuart MJ, Nagel RL, and Jefferson T. (2004). Sickle-cell disease. Lancet 364, 1343-1360.
101. Taha H, Skrzypek K, Guevara I, et al. (2010). Role of heme oxygenase-1 in human endothelial cells: Lesson from the promoter allelic variants. Arterioscler Thromb Vasc Biol 30, 1634-1641.
102. Taylor VI JG, Tang DC, Savage SA, et al. (2002). Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 100, 4303-4309.
103. Thuilliez V, Ditsambou V, Mba JR, Mba MS, and Kitengue J. (1996). Aspects actuels de la drepanocytose chez l'enfant au Gabon. Arch Pediatr 3, 668-674.
104. Tracz MJ, Alam J, and Nath KA. (2007). Physiology and pathophysiology of Heme: Implications for kidney disease. J Am Soc Nephrol 18, 414-420.
105. van Eps LW, Schouten H, Romeny-Wachter CC, and Porte-Wijsman LW. (1970). The relation between age and renal concentrating capacity in sickle cell disease and hemoglobin C disease. Clin Chim Acta 27, 501-511.
106. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, and Lubin B. (1990). Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 322, 1617-1621.
107. Wang WC, Pavlakis SG, Helton KJ, et al. (2008). MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr Blood Cancer 51, 643-6.
108. Wonkam A, Ngo Bitoungui VJ, Vorster AA, et al. (2014). Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon. PLoS One 9, e92506.
109. Xu J, Sankaran VG, Ni M, et al. (2010). Transcriptional silencing of c-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev 24, 783-789.
110. Yamada N, Yamaya M, Okinaga S, et al. (2000). Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 66, 187-195.
111. Yetunde A, and Anyaegbu. CC (2001). Profile of the Nigerian sickle cell anaemia patients above 30 years of age. Cent Afr J Med 47, 108-111.